Sai Life Sciences has developed an integrated cell permeability platform to support drug discovery through automation and scalable high-throughput screening. […]
Silver for Sustainability
9 Aug 2022
We have retained the Silver rating and increased our overall score this year at the EcoVadis Assessment, the world’s most trusted business sustainability rating.
In the industry category “manufacture of basic pharmaceutical products and pharmaceutical preparation,” our overall score has increased from 57 to 63.
The key contributors in score improvement: Sai Life Sciences becoming a Signatory to UNGC principles, ISO 14001/45001 and ISO 27001 standards, CDP reporting, Sustainable Procurement Framework and enterprise-wide Energy Conservation efforts.
Ecovadis rates more than 90,000 companies worldwide. This year’s assessment included new criteria in critical areas such as climate change, employee engagement with measured outcomes and quantifiable impact, diversity & inclusion, and continuous engagement with external stakeholders.
With a Gold rating in sight, the team continues its efforts towards all round improvement in the areas of Health, Safety, Environment, ethics, labor & human rights and sustainable procurement.
We thank all Saimers for contributing to this improvement in the Ecovadis score.
Related News
Sai Life Sciences and AstraZeneca have published a study titled “ReactIR Monitoring of Turbo-Hauser Base Formation Enables a Robust Iodination […]
21 May 2026
As drug discovery programs increasingly demand faster optimization cycles and access to broader chemical space, advanced chemistry approaches are moving […]